Tag: renal denervation

PCR e-Course 2020: Sham patients from RADIANCE-HTN SOLO who crossed over to denervation had reduced blood pressure

Patients who crossed over from the sham control arm of the RADIANCE-HTN SOLO trial to the renal ...
Michael Bohm

Virtual ACC: Renal denervation bests sham control to safely lower blood pressure in patients with untreated hypertension

Three months after undergoing renal denervation, patients with untreated high blood pressure had...

Renal denervation still holds strong potential as a therapy for hypertension

Although renal denervation may not hit the heights originally envisaged for it in the management of ...

TARGET BP I trial enrols its first patient

The first patient has been randomised in the TARGET BP I trial at the Piedmont Heart Institute i...

EuroPCR 2019: Renal denervation linked to reduction in subclinical atrial fibrillation

Data presented at EuroPCR today indicates that renal denervation with the Symplicity system (Med...

RADIANCE SOLO HTN finds greater blood pressure drop after renal denervation

Six-month "on-medication" results from the RADIANCE-HTN SOLO clinical trial have found that patients...

CRT 2019: Renal denervation using alcohol “seems very effective”

 The renal denervation bubble collapsed due to a single trial—SYMPLICITY HTN-3, but this trial’s...

CRT 2019: Redesigning the resurgence of renal denervation

 David Kandzari (Atlanta, USA) tells Cardiovascular News at CRT 2019 that renal denervation is typ...

The resurgence of renal denervation

More than ever before, arterial hypertension represents one of the greatest health threats and c...

US FDA approve new study of Medtronic’s Spyral renal denervation system

The FDA have given Medtronic approval to begin a clinical trial to evaluate the Symplicity Spyra...

Otsuka Medical Devices, Otsuak Holdings, and ReCor Medical to merge

Otsuka Holdings, Otsuka Medical Devices, and ReCor Medical have signed a merger agreement pursua...

FDA approves RADIANCE-II study of Paradise ultrasound denervation system

The RADIANCE-II study of the Paradise Ultrasound Denervation System (ReCor Medical) for the trea...

EuroPCR 2018: Will SPYRAL-ON change my practice?

In this PCR video, David E Kandzari (Department of Interventional Cardiology, Piedmont Heart Institu...

EuroPCR 2018: Positive data for renal denervation reignites interest in field

After two studies indicated that renal denervation lowers blood pressure both with and without a...

New trial of Symplicity Spyral approved

Medtronic has announced US FDA approval to begin an investigational device exemption (IDE) pivot...

From SYMPLICITY HTN-1 to SPYRAL HTN-OFF MED: The story of renal denervation

It is now almost a decade since the first patient underwent catheter-based renal denervation as ...

ESC 2017: MobiusHD implant shown to reduce resistant hypertension

The European results of the first-in-human trial of Vascular Dynamics’ MobiusHD implant indicate...

ESC 2017: SPYRAL HTN-OFF MED provides “proof of principle” that renal denervation works

Results from SPYRAL HTN-OFF MED indicate that renal denervation, compared with a sham procedure,...

Renal denervation devices are alternatives to drug therapy, Technavio reports

Analysts from Technavio have forecast the global renal denervation market to grow at a compound annu...